Catatonic syndrome in adults at Basurto Hospital: incidence, comorbidity, and short-term outcomes
Official title: Catatonic Syndrome in Adult Patients at Basurto Hospital: A Descriptive Study of Incidence, Comorbidity, and Short-Term Outcomes
Run by University of the Basque Country (UPV/EHU) · NCT07315386 · Data updated 2026-11-12
This project will follow adults with catatonia treated at Basurto Hospital to see how often it happens, what other conditions they have, and how they respond to short-term treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of the Basque Country (UPV/EHU) Academic / other |
| Locations | 1 site (Bilbao, Vizcaya) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2030 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT07315386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who are diagnosed with catatonia by DSM-5 criteria while being treated at Basurto University Hospital and who (or whose legal representative) provide informed consent.
✕Probably not a fit
People under 18, patients treated outside Basurto Hospital, or those who decline or withdraw consent will not be included and will not directly benefit from this study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
From January 2024 to December 2025, investigators will prospectively collect clinical and sociodemographic data on all adults (≥18) diagnosed with catatonia at Basurto University Hospital in emergency and inpatient settings. Diagnoses must meet DSM-5 criteria and consent (including deferred consent in acute cases) will be obtained; researchers will record comorbidities, treatments given, treatment responses, and short-term outcomes. The study is observational and descriptive, aiming to quantify incidence rates and characterize patient profiles rather than test new therapies. Results will be used to inform local clinical pathways and help plan future research on catatonia care.
Why it matters
Potential benefit: If successful, the project could help clinicians recognize catatonia earlier and choose effective treatments more quickly, improving recovery and reducing complications.
How similar studies have gone: Previous hospital-based and population studies have reported variable incidence and helped identify risk patterns, so this work builds on existing epidemiologic research rather than testing a new treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age ≥ 18 years at the time of hospital care. * Diagnosis of catatonic syndrome established according to DSM-5 criteria. * Patients attended at Basurto University Hospital in any clinical setting, including the Emergency Department or inpatient physical or psychiatric units. * Diagnosis made during the study period, from 1 January 2024 to 31 December 2025. * Catatonia of any etiology, including psychiatric, neurological, medical, metabolic, toxic, or autoimmune causes. * Provision of informed consent by the patient or their legal representative, when clinically feasible; deferred consent accepted in cases of acute catatonia. Exclusion Criteria * Refusal to participate in the study by the patient or their legal representative. * Withdrawal of informed consent at any point during the study.
Where it's running
-
Beatriz Rodriguez Cabo
Bilbao, Vizcaya, Spain Recruiting
Study contacts
- Study coordinator: Beatriz Rodriguez-Cabo, Professor
- Email: beatriz.rodriguez@ehu.eus
- Phone: +34944006066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
EEG microstates and inflammatory biomarkers in older adults with major depression receiving ECT
This study tests how ECT affects brain wave patterns and inflammatory markers in people 55 and older with major depression.
-
Measuring lorazepam blood levels in adults treated for catatonia
This research will measure lorazepam blood levels in adults with catatonia to see if those levels relate to how well the medication works.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.